1-20 of 65
Authors: Marco Valgimigli
Save search
Sort by
Journal Article

Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months Get access

PDF
Robert A Byrne and others
European Heart Journal, ehaf070, https://doi.org/10.1093/eurheartj/ehaf070
Published: 08 March 2025
Journal Article

Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution Get access

PDF
Marco Valgimigli and Antonio Landi
European Heart Journal, Volume 45, Issue 36, 21 September 2024, Pages 3732–3734, https://doi.org/10.1093/eurheartj/ehae542
Published: 28 August 2024
Journal Article

One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?

PDF
Francesco Costa and others
European Heart Journal, Volume 45, Issue 1, 1 January 2024, Pages 71–72, https://doi.org/10.1093/eurheartj/ehad729
Published: 20 November 2023
Journal Article
EDITOR'S CHOICE

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials

PDF
Francesco Costa and others
European Heart Journal, Volume 44, Issue 11, 14 March 2023, Pages 954–968, https://doi.org/10.1093/eurheartj/ehac706
Published: 07 December 2022
Journal Article
EDITOR'S CHOICE

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis

PDF
Marco Valgimigli and others
European Heart Journal, Volume 43, Issue 33, 1 September 2022, Pages 3100–3114, https://doi.org/10.1093/eurheartj/ehac284
Published: 22 June 2022
Journal Article

Not only lungs: COVID-19 hits platelets as well

PDF
Dario Bongiovanni and others
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2092–2093, https://doi.org/10.1093/eurheartj/ehac076
Published: 18 February 2022
Journal Article

Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum

PDF
Thomas F Lüscher and others
European Heart Journal, Volume 43, Issue 10, 7 March 2022, Pages 940–958, https://doi.org/10.1093/eurheartj/ehab642
Published: 08 October 2021
Journal Article

Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

PDF
Gerhard Hindricks and others
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Page 4194, https://doi.org/10.1093/eurheartj/ehab648
Published: 14 September 2021
Journal Article

Management of acute coronary syndromes in older adults

PDF
Nuccia Morici and others
European Heart Journal, Volume 43, Issue 16, 21 April 2022, Pages 1542–1553, https://doi.org/10.1093/eurheartj/ehab391
Published: 04 August 2021
Journal Article

Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

PDF
Eliano P Navarese and others
European Heart Journal, Volume 42, Issue 45, 1 December 2021, Pages 4638–4651, https://doi.org/10.1093/eurheartj/ehab246
Published: 18 May 2021
Journal Article

Patient-tailored antithrombotic therapy following percutaneous coronary intervention

PDF
Niels M R van der Sangen and others
European Heart Journal, Volume 42, Issue 10, 7 March 2021, Pages 1038–1046, https://doi.org/10.1093/eurheartj/ehaa1097
Published: 29 January 2021
Journal Article

European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

PDF
Christian Pristipino and others
European Heart Journal, Volume 42, Issue 16, 21 April 2021, Pages 1545–1553, https://doi.org/10.1093/eurheartj/ehaa1070
Published: 28 January 2021
Journal Article
EDITOR'S CHOICE

Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials

PDF
Daniele Giacoppo and others
European Heart Journal, Volume 42, Issue 4, 21 January 2021, Pages 308–319, https://doi.org/10.1093/eurheartj/ehaa739
Published: 07 December 2020
Journal Article

Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk

PDF
Noé Corpataux and others
European Heart Journal, Volume 41, Issue 38, 7 October 2020, Pages 3743–3749, https://doi.org/10.1093/eurheartj/ehaa671
Published: 08 October 2020
Journal Article

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

PDF
Pascal Vranckx and others
European Heart Journal, Volume 41, Issue 47, 14 December 2020, Pages 4497–4504, https://doi.org/10.1093/eurheartj/ehaa617
Published: 29 August 2020
Journal Article

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

PDF
Gerhard Hindricks and others
European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 373–498, https://doi.org/10.1093/eurheartj/ehaa612
Published: 29 August 2020
Journal Article

Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help

PDF
Giuseppe Gargiulo and others
European Heart Journal, Volume 41, Issue 17, 1 May 2020, Pages 1701–1702, https://doi.org/10.1093/eurheartj/ehaa076
Published: 14 February 2020
Journal Article

Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelines Get access

PDF
Robert F Storey and others
European Heart Journal, Volume 41, Issue 3, 14 January 2020, Pages 483–484, https://doi.org/10.1093/eurheartj/ehz894
Published: 23 December 2019
Journal Article
EDITOR'S CHOICE

Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

PDF
Giuseppe Gargiulo and others
European Heart Journal, Volume 40, Issue 46, 7 December 2019, Pages 3757–3767, https://doi.org/10.1093/eurheartj/ehz732
Published: 25 October 2019
Journal Article

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

PDF
Juhani Knuuti and others
European Heart Journal, Volume 41, Issue 3, 14 January 2020, Pages 407–477, https://doi.org/10.1093/eurheartj/ehz425
Published: 31 August 2019